Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-23-000607
Filing Date
2023-04-07
Accepted
2023-04-07 16:01:15
Documents
11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS cvs4106991-defa14a.htm DEFA14A 38452
2 GRAPHIC logo.jpg GRAPHIC 11185
3 GRAPHIC cvs4106991-defa14ax1x1.jpg GRAPHIC 48251
4 GRAPHIC cvs4106991x1x1.jpg GRAPHIC 10986
5 GRAPHIC cvs4106991-defa14ax1x2.jpg GRAPHIC 5163
6 GRAPHIC cvs4106991-defa14ax1x3.jpg GRAPHIC 3186
7 GRAPHIC cvs4106991-defa14ax1x4.jpg GRAPHIC 7360
8 GRAPHIC cvs4106991-defa14ax1x5.jpg GRAPHIC 6871
9 GRAPHIC cvs4106991-defa14ax2x1b.jpg GRAPHIC 1098
10 GRAPHIC one.jpg GRAPHIC 1101
11 GRAPHIC cvs4106991-defa14ax2x1c.jpg GRAPHIC 1108
  Complete submission text file 0001308179-23-000607.txt   173847
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

EIN.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-01011 | Film No.: 23808776
SIC: 5912 Retail-Drug Stores and Proprietary Stores